Role of alcohol in the progression of liver disease caused by hepatitis C virus infection

Hepatology

Volumn 27, Issue 6, 1998, Pages 1730-1735

  Ostapowicz, George ^a   Watson, Katrina J R ^a   Locarnini, Stephen A ^b   Desmond, Paul V ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; HEPATITIS C ANTIBODY;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; AUSTRALIA; CHRONIC HEPATITIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; VIRUS TITRATION;

ADULT; AGE FACTORS; ALCOHOL DRINKING; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; MALE; RISK FACTORS;

EID: 0031749109     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510270637     Document Type: Article

References (27)

1. Esteban JI, Lopez-Talavera JC, Genesca J, Madoz P, Viladomiu L, Martin-Vega C, et al. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus. Ann Intern Med 1991;115: 443-449.
2. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander J, Hu PY, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992;327:1899-1905.
3. Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. HEPATOLOGY 1991;14:969-974.
4. Koretz RL, Abbey H, Coleman E, Gitnick G. Non-A, non-B posttransfusion hepatitis: looking back in the second decade. Ann Intern Med 1993;119:110-115.
5. Strasser SI, Watson KJR, Lee CS, Coghlan PJ, Desmond PV. Risk factors and predictors of outcome in an Australian cohort with hepatitis C virus infection. Med J Aust 1995;162:355-358.
6. Dusheiko G, Schmilovitz-Weiss H, Brown D, McOmish E. Yap P, Sherlock S, McIntyre N, et al. Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. HEPATOLOGY 1994;19:13-18.
7. Romeo R, Colombo M, Rumi M, Soffredini R, Del Ninno E, Russo A, Simmonds P. Lack of association between type of hepatitis C virus, serum load and severity of liver disease. J Viral Hepat 1996;3:183-190.
8. Benvegnu L, Pontisso P, Cavalletto D, Noventa F, Chemello L, Alberti A. Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis. HEPATOLOGY 1997;25:211-215.
9. Kato N, Osamu Y, Hosoda K, Ito Y, Ohto M, Omata M. Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease. HEPATOLOGY 1993;18:16-20.
10. Hagiwara H, Hayashi N, Mita E, Naito M, Kasahara A, Fusamoto H, Kamada T. Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease. HEPATOLOGY 1993;17:545-550.
11. Hollingsworth R, Sillikens P, van Deursen P, Neal K, Irving W. Serum HCV RNA levels assessed by quantitative NASBA: stability of viral load over time, and lack of correlation with liver disease. J Hepatol 1996;25: 301-306.
12. Honda M, Kaneko S, Sakai A, Unoura M, Murakami S, Kobayashi K. Degree of diversity of hepatitis C virus quasispecies and progression of liver disease. HEPATOLOGY 1994;20:1144-1151.
13. Weltman M, Brotodihardjo A, Crewe E, Farrell G, Bilous M, Grierson J, Liddle C. Coinfection with hepatitis B and C or B, C and D viruses results in severe liver disease and responds poorly to interferon-α treatment. J Viral Hepat 1995;2:39-45.
14. Farinati F, Cardin R, De Maria N, Della Libera G, Marafin C, Lecis E, Burra P, et al. Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol 1995;22:449-456.
15. Haque S, Chandra B, Gerber M, Lok A. Iron overload in patients with chronic hepatitis C: a clinicopathologic study. Hum Pathol 1996;27:1377-1381.
16. Jenkins P, Cromie S, Roberts S, Finch C, Dudley F. Chronic hepatitis C, alcohol and hepatic fibrosis [Abstract]. HEPATOLOGY 1996;24:153A.
17. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997;349:825-832.
18. Selvey L, Sririjalingam M, Crawford D, Leggett B, Cooksley W. Alcohol does not play a significant role in promoting cirrhosis in chronic hepatitis C: analysis of 102 patients [Abstract]. HEPATOLOGY 1994;20: 254A.
19. Skinner HA, Sheu WJ. Reliability of alcohol use indices: lifetime drinking history and MAST. J Stud Alcohol 1982;43:1157-1170.
20. Knodell R, Ishak G, Black W, Chen TS, Craig R, Kaplowitz N, Kiernan TW, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. HEPATOLOGY 1981;1:431-435.
21. Scheuer P. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991;13:372-374.
22. Izopet J, Bogard M, Costes J, Duverlie G, Halfon P, Ouzan D, Puel J, et al. Multicentre evaluation of analytical performances of the Amplicor HCV RNA qualitative test [Abstract]. HEPATOLOGY 1994;20(Suppl):241A.
23. Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, Van Heuverswyn H, Maertens G, et al. Typing of hepatitis C virus isolates and characterisation of new subtypes using a line probe assay. J Gen Virol 1993;74:1093-1102.
24. Loiseau P, Stuyver L, Ravera N, Wolfe L, Benbuban M, Sayada C. HCV Amplicor-LIPA combined procedure: validation and benefits [Abstract]. HEPATOLOGY 1994;20(Suppl):241A.
25. Mutimer D, Harrison R, O'Donnell K, Shaw J, Martin B, Atrah H, Ala F, et al. Hepatitis C virus infection in the asymptomatic British blood donor. J Viral Hepat 1995;2:47-53.
26. Crowe J, Doyle C, Fielding J, Holloway H, Keegan M, Kelleher D Kelly P, et al. Presentation of hepatitis C in a unique uniform cohort 17 years from inoculation [Abstract]. Gastroenterology 1995;108:A1054.
27. Tong M, el-Farra N, Reikes A, Co R. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995;332:1463-1466.